CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$87.75
−18.38%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.14x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.33x
- Net debt / EBITDA
- -3.53x
Liquidity & coverage
- Current ratio
- 2.86x
- Quick ratio
- 2.77x
- Cash ratio
- 2.00x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $285.9M
Cash & dividend
- FCF / debt
- 11.35x
- Cash flow / debt
- 11.64x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026